These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 10724108

  • 1. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M, Asahi K, Wang X, Lo EH.
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y, Li Q, Shuaib A.
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [Abstract] [Full Text] [Related]

  • 3. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M, Rammohan R, Sumii T, Wang X, Pauw RJ, Weissig V, Torchilin VP, Lo EH.
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [Abstract] [Full Text] [Related]

  • 4. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
    Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH.
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA, Chapman DF, Zivin JA.
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [Abstract] [Full Text] [Related]

  • 7. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke.
    Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ.
    Circulation; 2007 Jul 24; 116(4):411-8. PubMed ID: 17606844
    [Abstract] [Full Text] [Related]

  • 8. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T, Lo EH.
    Stroke; 2002 Mar 24; 33(3):831-6. PubMed ID: 11872911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A, Yang Y, Nakada MT, Li Q, Yang T.
    J Cereb Blood Flow Metab; 2002 Feb 24; 22(2):215-22. PubMed ID: 11823719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats.
    Aronowski J, Strong R, Grotta JC.
    J Cereb Blood Flow Metab; 1997 Oct 24; 17(10):1048-56. PubMed ID: 9346429
    [Abstract] [Full Text] [Related]

  • 13. Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model.
    Ninomia T, Wang L, Kumar SR, Kim A, Zlokovic BV.
    J Cereb Blood Flow Metab; 2000 Jun 24; 20(6):998-1009. PubMed ID: 10894183
    [Abstract] [Full Text] [Related]

  • 14. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
    Yi JS, Kim YH, Koh JY.
    Exp Neurol; 2004 Oct 24; 189(2):354-60. PubMed ID: 15380485
    [Abstract] [Full Text] [Related]

  • 15. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA, Shuaib A, Todd KG.
    Exp Neurol; 2006 Jul 24; 200(1):38-49. PubMed ID: 16624294
    [Abstract] [Full Text] [Related]

  • 16. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX, Ding X, Shuaib A.
    Exp Neurol; 2008 Sep 24; 213(1):171-5. PubMed ID: 18598697
    [Abstract] [Full Text] [Related]

  • 17. Effects of the nitrone radical scavengers PBN and S-PBN on in vivo trapping of reactive oxygen species after traumatic brain injury in rats.
    Marklund N, Lewander T, Clausen F, Hillered L.
    J Cereb Blood Flow Metab; 2001 Nov 24; 21(11):1259-67. PubMed ID: 11702041
    [Abstract] [Full Text] [Related]

  • 18. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY, Lee MY, Chen HY, Kuo YL, Lin SC, Wu TS, Lee EJ.
    J Pineal Res; 2006 Apr 24; 40(3):242-50. PubMed ID: 16499561
    [Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T, Kano T, Katayama Y, Matsuzaki T, Tejima E, Koshinaga M.
    Thromb Haemost; 2005 Oct 24; 94(4):791-6. PubMed ID: 16270632
    [Abstract] [Full Text] [Related]

  • 20. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L, Zhang ZG, Liu X, Hozeska A, Stagliano N, Riordan W, Lu M, Chopp M.
    Thromb Haemost; 2006 Jan 24; 95(1):166-73. PubMed ID: 16543976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.